Zynerba Pharma CS (ZYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZYNE | SLGL | MGX | ||
| Company | Zynerba Pharma CS | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.2600 | 74.80 | 1.4700 | ||
| High | 1.3400 | 83.25 | 1.4700 | ||
| Low | 1.2600 | 74.80 | 1.4200 | ||
| Latest | 1.3000 | 76.01 | 1.4400 | ||
| Change | +0.0300 | +3.71 | +0.0100 | ||
| % Change | +2.36% | +5.13% | +0.70% | ||
| Volume | 862,700 | 31,332 | 35,076 | ||
| 20-Day Average Volume | 1,093,995 | 63,085 | 197,535 | ||
| Previous Close | 1.2700 | 72.30 | 1.4300 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.3012 | 75.28 | 1.4038 | ||
| 20-Day Raw Stochastic | 53.49% | 60.36% | 66.67% | ||
| 20-Day Relative Strength | 62.80 | 51.21 | 49.44 | ||
| Weighted Alpha | -35.90 | +412.49 | -27.76 | ||
| Today's Opinion | 80% Buy | 56% Buy | 80% Sell | ||
| Previous Opinion | 80% Buy | 40% Buy | 80% Sell | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.17% since 10/03/23 | +4.64% since 04/17/26 | -2.03% since 04/17/26 | ||
| Low | 1.1850 on 10/04/23 | 69.61 on 04/20/26 | 1.4000 on 04/23/26 | ||
| High | 1.3400 on 10/10/23 | 83.25 on 04/24/26 | 1.5500 on 04/21/26 | ||
| 1-Month | |||||
| %Chg | -1.52% since 09/08/23 | -3.39% since 03/24/26 | +5.84% since 03/24/26 | ||
| Low | 1.1850 on 10/04/23 | 65.07 on 03/30/26 | 1.2500 on 03/30/26 | ||
| High | 1.4000 on 09/15/23 | 85.32 on 04/01/26 | 1.5500 on 04/21/26 | ||
| 3-Month | |||||
| %Chg | +293.70% since 07/10/23 | +32.26% since 01/23/26 | -14.20% since 01/23/26 | ||
| Low | 0.2500 on 07/11/23 | 55.51 on 01/26/26 | 1.2500 on 03/30/26 | ||
| High | 1.4000 on 09/15/23 | 97.97 on 03/03/26 | 1.8250 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +225.00% since 04/10/23 | +98.19% since 10/24/25 | -49.83% since 10/24/25 | ||
| Low | 0.2500 on 07/11/23 | 28.81 on 11/13/25 | 1.2500 on 03/30/26 | ||
| High | 1.4000 on 09/15/23 | 97.97 on 03/03/26 | 2.9399 on 10/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 70,121 | 203,156 | 53,798 | ||
| Shares Outstanding, K | 53,939 | 2,810 | 37,621 | ||
| Annual Sales | 0 | 19,390,000 | 25,210,000 | ||
| Annual Net Income | -35,040,000 | -6,130,000 | -87,870,000 | ||
| Last Quarter Sales | 0 | 700,000 | 3,910,000 | ||
| Last Quarter Net Income | -10,780,000 | -2,990,000 | -22,530,000 | ||
| 60-Month Beta | 1.32 | 1.26 | 0.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 08/14/23 | -1.07 on 03/19/26 | -0.60 on 03/05/26 | ||
| Latest Earnings Date | 11/13/23 | 05/22/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||